It has been confirmed that patients with MS have elevated levels of oxidative stress markers such as total oxidative status (TOS), malondialdehyde (MDA), and oxidative stress index (OSI) while impaired expression of antioxidant markers, including total antioxidant status (TAS) and superoxide dismutase (SOD) [23]. The gene discussed is SOD1; the disease is myeloid sarcoma.